Skip to content

Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score

Functional and Anatomical Testing in Intermediate Risk Chest Pain Patients With Severe Coronary Calcium Score

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03548753
Acronym
FACC
Enrollment
278
Registered
2018-06-07
Start date
2016-09-02
Completion date
2018-04-30
Last updated
2018-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observational

Keywords

Angina, Chest pain, Diagnostic tests

Brief summary

A prospective, blinded multicenter study for evaluation of chest pain patients with severe coronary calcium (Agatston score \> 399). The objective is to evaluate if an initial non-invasive strategy with coronary computed tomography angiography (CCTA) including functional flow reserve derived from CCTA (FFR-CT) is as effective as invasive coronary angiography (ICA) including functional flow reserve (FFR) for the detection and exclusion of obstructive coronary artery disease (CAD). Study hypothesis: initial non-invasive anatomic and functional testing is non-inferior to an invasive anatomic and functional testing strategy.

Detailed description

Prospective, blinded multicenter study evaluating the diagnostic performance of coronary computed tomography angiography (CCTA) including functional flow reserve derived from CCTA (FFR-CT) for the detection and exclusion of significant obstructive coronary artery disease (CAD). The reference standard vil be invasive coronary angiography (ICA) including functional flow reserve (FFR). Patients referred for elective CCTA because of suspected stable CAD are considered. If the initial routine non-enhanced CT scan shows an Agatston score \> 399, the patient is eligible for study inclusion. Four sites in the region of Southern Denmark will participate (Odense University Hospital, Svendborg Hospital, Vejle Hospital and Esbjerg Hospital). A total of 278 patients will be included.

Interventions

None listed

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age ≥ 18 years * An estimated likelihood for the presence of significant CAD between 15% and 85% * Clinical stable patients with symptoms of suspected CAD referred for CTTA * Initial routine non-enhanced CT scan shows an Agatston score \>399 * Written informed consent * Accept to undergo elective invasive coronary angiography (ICA) within 90 days

Exclusion criteria

* Known prior myocardial infarction * Prior percutaneous coronary intervention (PCI) * Prior coronary artery bypass surgery (CABG) * Pacemaker or internal defibrillator lead implantation * Prosthetic heart valve * Atrial fibrillation * Renal Insufficiency (\<40 mL/min) * Known anaphylactic reaction to iodinated contrast * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Per-patient diagnostic accuracy of functional flow reserve (FFR-CT) derived from standard coronary computed tomography angiography (CCTA) compared to invasive coronary angiography (ICA) including functional flow ratio (FFR)Comparison of the noninvasive and invasive diagnostic modalities is performed at least 90 days after enrollment of each of the included patientsThe primary outcome measure is the per-patient diagnostic accuracy of functional flow reserve (FFR-CT) derived from standard coronary computed tomography angiography (CCTA) compared to invasive coronary angiography (ICA) including functional flow ratio (FFR), which is considered the gold standard in the detection or exclusion of obstructive coronary artery disease (CAD)

Secondary

MeasureTime frameDescription
Coronary revascularization procedures90 day after inclusionPercentage of coronary revascularization procedures (PCI and CABG) in patients with reduced FFR-CT vs. patients with normal FFR-CT
Other clinical endpoints90 days after inclusionPercentage of patients with the composite endpoint of all-cause mortality or myocardial infarction or unstable angina hospitalization
Major complications from diagnostic invasive diagnostic proceduresWithin 72 hours after invasive procedurePercentage of patients with major complications following invasive coronary angiography (ICA) including fractional flow reserve (FFR) measurement
Invasive coronary angiography (ICA) including functional flow ratio (FFR) without obstructive coronary artery disease90 days after inclusionPercentage of patients with invasive coronary angiography (ICA) including functional flow reserve (FFR) measurement without evidence of obstructive coronary artery disease
Per-vessel correlation of FFR-CT numerical value with the FFR numerical value in patients undergoing FFRAt least 90 days after patient inclusionThe per-vessel correlation of FFRCT numerical value with the FFR numerical value in patients undergoing FFR
The diagnostic accuracy of FFR-CT in subgroups of patients with high calcium score vs. patients with very high calcium scoreAt least 90 days after patient inclusionComparison of the diagnostic accuracy of FFR-CT in subgroups of patients with high calcium score (Agatston score 400-999) vs patients with very high calcium score (Agatston score ≥ 999)
Costs and resource use.90 days after inclusionEstimating the total costs of potentially unnecessary invasive coronary angiographies with functional flow ratio measurements
Per-patient and per-vessel diagnostic performance of FFR-CT by means of accuracy, sensitivity, specificity, positive predictive value, and negative predictive valueAt least 90 days after patient inclusionAssessing per-patient and per-vessel diagnostic performance of FFR-CT by means of accuracy, sensitivity, specificity, positive predictive value, and negative predictive value

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026